aluates Reports

$ 0.0

Automative

Global Artificial Intelligence in Biomedical Market Research Report 2026

Published Date: 2026-01-21

Report Code: QYRE-Auto-33S19787

Global Artificial Intelligence in Biomedical Market Outlook In Depth Analysis Forecast to 2031

BUY CHAPTERS

Global Artificial Intelligence in Biomedical Market Research Report 2026

Code: QYRE-Auto-33S19787

Report

2026-01-21

Pages:160

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Artificial Intelligence in Biomedical Market Size

The global Artificial Intelligence in Biomedical market was valued at US$ 250 million in 2025 and is anticipated to reach US$ 1545 million by 2032, at a CAGR of 30.1% from 2026 to 2032.

Artificial Intelligence in Biomedical Market

Artificial Intelligence (AI) in biomedical refers to the application of AI technologies, such as machine learning, natural language processing, and computer vision, in the fields of medicine and biology. It is used to analyze complex biomedical data, assist in diagnostics, develop personalized treatment plans, discover new drugs, and improve healthcare outcomes. AI enhances the accuracy, speed, and efficiency of medical and biological research and clinical practices.

The North American market for Artificial Intelligence in Biomedical is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Artificial Intelligence in Biomedical is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Artificial Intelligence in Biomedical in Diagnosing Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Artificial Intelligence in Biomedical include AstraZeneca, Thales Group, IBM Corp., ForeSee Medical, Atomwise, Cloud Pharmaceuticals, GNS Healthcare, Microsoft Corporation, Novartis AG, NVIDIA Corporation, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Artificial Intelligence in Biomedical market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Artificial Intelligence in Biomedical. The Artificial Intelligence in Biomedical market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Artificial Intelligence in Biomedical market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Artificial Intelligence in Biomedical manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Artificial Intelligence in Biomedical Market Report

Report Metric	Details
Report Name	Artificial Intelligence in Biomedical Market
Accounted market size in 2025	US$ 250 million
Forecasted market size in 2032	US$ 1545 million
CAGR	30.1%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Hardware Software
Segment by Application	Diagnosing Diseases Developing Drugs Personalized Treatment Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca, Thales Group, IBM Corp., ForeSee Medical, Atomwise, Cloud Pharmaceuticals, GNS Healthcare, Microsoft Corporation, Novartis AG, NVIDIA Corporation, Pfizer, Recursion Pharmaceuticals, XtalPi Inc, Aidoc, AliveCor, GE Healthcare, Imagen Technologies, Vuno Inc., IDx Technologies Inc., Siemens Healthcare GmbH, Neural Analytics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Artificial Intelligence in Biomedical companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Artificial Intelligence in Biomedical Market growing?

Ans: The Artificial Intelligence in Biomedical Market witnessing a CAGR of 30.1% during the forecast period 2026-2032.

What is the Artificial Intelligence in Biomedical Market size in 2032?

Ans: The Artificial Intelligence in Biomedical Market size in 2032 will be US$ 1545 million.

Who are the main players in the Artificial Intelligence in Biomedical Market report?

Ans: The main players in the Artificial Intelligence in Biomedical Market are AstraZeneca, Thales Group, IBM Corp., ForeSee Medical, Atomwise, Cloud Pharmaceuticals, GNS Healthcare, Microsoft Corporation, Novartis AG, NVIDIA Corporation, Pfizer, Recursion Pharmaceuticals, XtalPi Inc, Aidoc, AliveCor, GE Healthcare, Imagen Technologies, Vuno Inc., IDx Technologies Inc., Siemens Healthcare GmbH, Neural Analytics

What are the Application segmentation covered in the Artificial Intelligence in Biomedical Market report?

Ans: The Applications covered in the Artificial Intelligence in Biomedical Market report are Diagnosing Diseases, Developing Drugs, Personalized Treatment, Other

What are the Type segmentation covered in the Artificial Intelligence in Biomedical Market report?

Ans: The Types covered in the Artificial Intelligence in Biomedical Market report are Hardware, Software

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Artificial Intelligence in Biomedical Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Hardware

1.2.3 Software

1.3 Market by Application

1.3.1 Global Artificial Intelligence in Biomedical Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Diagnosing Diseases

1.3.3 Developing Drugs

1.3.4 Personalized Treatment

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Artificial Intelligence in Biomedical Market Perspective (2021–2032)

2.2 Global Artificial Intelligence in Biomedical Growth Trends by Region

2.2.1 Global Artificial Intelligence in Biomedical Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Artificial Intelligence in Biomedical Historic Market Size by Region (2021–2026)

2.2.3 Artificial Intelligence in Biomedical Forecasted Market Size by Region (2027–2032)

2.3 Artificial Intelligence in Biomedical Market Dynamics

2.3.1 Artificial Intelligence in Biomedical Industry Trends

2.3.2 Artificial Intelligence in Biomedical Market Drivers

2.3.3 Artificial Intelligence in Biomedical Market Challenges

2.3.4 Artificial Intelligence in Biomedical Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Artificial Intelligence in Biomedical Players by Revenue

3.1.1 Global Top Artificial Intelligence in Biomedical Players by Revenue (2021–2026)

3.1.2 Global Artificial Intelligence in Biomedical Revenue Market Share by Players (2021–2026)

3.2 Global Top Artificial Intelligence in Biomedical Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Artificial Intelligence in Biomedical Revenue

3.4 Global Artificial Intelligence in Biomedical Market Concentration Ratio

3.4.1 Global Artificial Intelligence in Biomedical Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence in Biomedical Revenue in 2025

3.5 Global Key Players of Artificial Intelligence in Biomedical Head Offices and Areas Served

3.6 Global Key Players of Artificial Intelligence in Biomedical, Products and Applications

3.7 Global Key Players of Artificial Intelligence in Biomedical, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Artificial Intelligence in Biomedical Breakdown Data by Type

4.1 Global Artificial Intelligence in Biomedical Historic Market Size by Type (2021–2026)

4.2 Global Artificial Intelligence in Biomedical Forecasted Market Size by Type (2027–2032)

5 Artificial Intelligence in Biomedical Breakdown Data by Application

5.1 Global Artificial Intelligence in Biomedical Historic Market Size by Application (2021–2026)

5.2 Global Artificial Intelligence in Biomedical Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Artificial Intelligence in Biomedical Market Size (2021–2032)

6.2 North America Artificial Intelligence in Biomedical Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Artificial Intelligence in Biomedical Market Size by Country (2021–2026)

6.4 North America Artificial Intelligence in Biomedical Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Artificial Intelligence in Biomedical Market Size (2021–2032)

7.2 Europe Artificial Intelligence in Biomedical Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Artificial Intelligence in Biomedical Market Size by Country (2021–2026)

7.4 Europe Artificial Intelligence in Biomedical Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Artificial Intelligence in Biomedical Market Size (2021–2032)

8.2 Asia-Pacific Artificial Intelligence in Biomedical Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Artificial Intelligence in Biomedical Market Size by Region (2021–2026)

8.4 Asia-Pacific Artificial Intelligence in Biomedical Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Artificial Intelligence in Biomedical Market Size (2021–2032)

9.2 Latin America Artificial Intelligence in Biomedical Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Artificial Intelligence in Biomedical Market Size by Country (2021–2026)

9.4 Latin America Artificial Intelligence in Biomedical Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Artificial Intelligence in Biomedical Market Size (2021–2032)

10.2 Middle East & Africa Artificial Intelligence in Biomedical Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Artificial Intelligence in Biomedical Market Size by Country (2021–2026)

10.4 Middle East & Africa Artificial Intelligence in Biomedical Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AstraZeneca

11.1.1 AstraZeneca Company Details

11.1.2 AstraZeneca Business Overview

11.1.3 AstraZeneca Artificial Intelligence in Biomedical Introduction

11.1.4 AstraZeneca Revenue in Artificial Intelligence in Biomedical Business (2021–2026)

11.1.5 AstraZeneca Recent Development

11.2 Thales Group

11.2.1 Thales Group Company Details

11.2.2 Thales Group Business Overview

11.2.3 Thales Group Artificial Intelligence in Biomedical Introduction

11.2.4 Thales Group Revenue in Artificial Intelligence in Biomedical Business (2021–2026)

11.2.5 Thales Group Recent Development

11.3 IBM Corp.

11.3.1 IBM Corp. Company Details

11.3.2 IBM Corp. Business Overview

11.3.3 IBM Corp. Artificial Intelligence in Biomedical Introduction

11.3.4 IBM Corp. Revenue in Artificial Intelligence in Biomedical Business (2021–2026)

11.3.5 IBM Corp. Recent Development

11.4 ForeSee Medical

11.4.1 ForeSee Medical Company Details

11.4.2 ForeSee Medical Business Overview

11.4.3 ForeSee Medical Artificial Intelligence in Biomedical Introduction

11.4.4 ForeSee Medical Revenue in Artificial Intelligence in Biomedical Business (2021–2026)

11.4.5 ForeSee Medical Recent Development

11.5 Atomwise

11.5.1 Atomwise Company Details

11.5.2 Atomwise Business Overview

11.5.3 Atomwise Artificial Intelligence in Biomedical Introduction

11.5.4 Atomwise Revenue in Artificial Intelligence in Biomedical Business (2021–2026)

11.5.5 Atomwise Recent Development

11.6 Cloud Pharmaceuticals

11.6.1 Cloud Pharmaceuticals Company Details

11.6.2 Cloud Pharmaceuticals Business Overview

11.6.3 Cloud Pharmaceuticals Artificial Intelligence in Biomedical Introduction

11.6.4 Cloud Pharmaceuticals Revenue in Artificial Intelligence in Biomedical Business (2021–2026)

11.6.5 Cloud Pharmaceuticals Recent Development

11.7 GNS Healthcare

11.7.1 GNS Healthcare Company Details

11.7.2 GNS Healthcare Business Overview

11.7.3 GNS Healthcare Artificial Intelligence in Biomedical Introduction

11.7.4 GNS Healthcare Revenue in Artificial Intelligence in Biomedical Business (2021–2026)

11.7.5 GNS Healthcare Recent Development

11.8 Microsoft Corporation

11.8.1 Microsoft Corporation Company Details

11.8.2 Microsoft Corporation Business Overview

11.8.3 Microsoft Corporation Artificial Intelligence in Biomedical Introduction

11.8.4 Microsoft Corporation Revenue in Artificial Intelligence in Biomedical Business (2021–2026)

11.8.5 Microsoft Corporation Recent Development

11.9 Novartis AG

11.9.1 Novartis AG Company Details

11.9.2 Novartis AG Business Overview

11.9.3 Novartis AG Artificial Intelligence in Biomedical Introduction

11.9.4 Novartis AG Revenue in Artificial Intelligence in Biomedical Business (2021–2026)

11.9.5 Novartis AG Recent Development

11.10 NVIDIA Corporation

11.10.1 NVIDIA Corporation Company Details

11.10.2 NVIDIA Corporation Business Overview

11.10.3 NVIDIA Corporation Artificial Intelligence in Biomedical Introduction

11.10.4 NVIDIA Corporation Revenue in Artificial Intelligence in Biomedical Business (2021–2026)

11.10.5 NVIDIA Corporation Recent Development

11.11 Pfizer

11.11.1 Pfizer Company Details

11.11.2 Pfizer Business Overview

11.11.3 Pfizer Artificial Intelligence in Biomedical Introduction

11.11.4 Pfizer Revenue in Artificial Intelligence in Biomedical Business (2021–2026)

11.11.5 Pfizer Recent Development

11.12 Recursion Pharmaceuticals

11.12.1 Recursion Pharmaceuticals Company Details

11.12.2 Recursion Pharmaceuticals Business Overview

11.12.3 Recursion Pharmaceuticals Artificial Intelligence in Biomedical Introduction

11.12.4 Recursion Pharmaceuticals Revenue in Artificial Intelligence in Biomedical Business (2021–2026)

11.12.5 Recursion Pharmaceuticals Recent Development

11.13 XtalPi Inc

11.13.1 XtalPi Inc Company Details

11.13.2 XtalPi Inc Business Overview

11.13.3 XtalPi Inc Artificial Intelligence in Biomedical Introduction

11.13.4 XtalPi Inc Revenue in Artificial Intelligence in Biomedical Business (2021–2026)

11.13.5 XtalPi Inc Recent Development

11.14 Aidoc

11.14.1 Aidoc Company Details

11.14.2 Aidoc Business Overview

11.14.3 Aidoc Artificial Intelligence in Biomedical Introduction

11.14.4 Aidoc Revenue in Artificial Intelligence in Biomedical Business (2021–2026)

11.14.5 Aidoc Recent Development

11.15 AliveCor

11.15.1 AliveCor Company Details

11.15.2 AliveCor Business Overview

11.15.3 AliveCor Artificial Intelligence in Biomedical Introduction

11.15.4 AliveCor Revenue in Artificial Intelligence in Biomedical Business (2021–2026)

11.15.5 AliveCor Recent Development

11.16 GE Healthcare

11.16.1 GE Healthcare Company Details

11.16.2 GE Healthcare Business Overview

11.16.3 GE Healthcare Artificial Intelligence in Biomedical Introduction

11.16.4 GE Healthcare Revenue in Artificial Intelligence in Biomedical Business (2021–2026)

11.16.5 GE Healthcare Recent Development

11.17 Imagen Technologies

11.17.1 Imagen Technologies Company Details

11.17.2 Imagen Technologies Business Overview

11.17.3 Imagen Technologies Artificial Intelligence in Biomedical Introduction

11.17.4 Imagen Technologies Revenue in Artificial Intelligence in Biomedical Business (2021–2026)

11.17.5 Imagen Technologies Recent Development

11.18 Vuno Inc.

11.18.1 Vuno Inc. Company Details

11.18.2 Vuno Inc. Business Overview

11.18.3 Vuno Inc. Artificial Intelligence in Biomedical Introduction

11.18.4 Vuno Inc. Revenue in Artificial Intelligence in Biomedical Business (2021–2026)

11.18.5 Vuno Inc. Recent Development

11.19 IDx Technologies Inc.

11.19.1 IDx Technologies Inc. Company Details

11.19.2 IDx Technologies Inc. Business Overview

11.19.3 IDx Technologies Inc. Artificial Intelligence in Biomedical Introduction

11.19.4 IDx Technologies Inc. Revenue in Artificial Intelligence in Biomedical Business (2021–2026)

11.19.5 IDx Technologies Inc. Recent Development

11.20 Siemens Healthcare GmbH

11.20.1 Siemens Healthcare GmbH Company Details

11.20.2 Siemens Healthcare GmbH Business Overview

11.20.3 Siemens Healthcare GmbH Artificial Intelligence in Biomedical Introduction

11.20.4 Siemens Healthcare GmbH Revenue in Artificial Intelligence in Biomedical Business (2021–2026)

11.20.5 Siemens Healthcare GmbH Recent Development

11.21 Neural Analytics

11.21.1 Neural Analytics Company Details

11.21.2 Neural Analytics Business Overview

11.21.3 Neural Analytics Artificial Intelligence in Biomedical Introduction

11.21.4 Neural Analytics Revenue in Artificial Intelligence in Biomedical Business (2021–2026)

11.21.5 Neural Analytics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

Table 1. Global Artificial Intelligence in Biomedical Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Hardware

Table 3. Key Players of Software

Table 4. Global Artificial Intelligence in Biomedical Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Artificial Intelligence in Biomedical Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Artificial Intelligence in Biomedical Market Size by Region (US$ Million), 2021–2026

Table 7. Global Artificial Intelligence in Biomedical Market Share by Region (2021–2026)

Table 8. Global Artificial Intelligence in Biomedical Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Artificial Intelligence in Biomedical Market Share by Region (2027–2032)

Table 10. Artificial Intelligence in Biomedical Market Trends

Table 11. Artificial Intelligence in Biomedical Market Drivers

Table 12. Artificial Intelligence in Biomedical Market Challenges

Table 13. Artificial Intelligence in Biomedical Market Restraints

Table 14. Global Artificial Intelligence in Biomedical Revenue by Players (US$ Million), 2021–2026

Table 15. Global Artificial Intelligence in Biomedical Market Share by Players (2021–2026)

Table 16. Global Top Artificial Intelligence in Biomedical Players by Tier (Tier 1, Tier 2, and Tier 3), based on Artificial Intelligence in Biomedical Revenue, 2025

Table 17. Ranking of Global Top Artificial Intelligence in Biomedical Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Artificial Intelligence in Biomedical Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Artificial Intelligence in Biomedical, Headquarters and Area Served

Table 20. Global Key Players of Artificial Intelligence in Biomedical, Products and Applications

Table 21. Global Key Players of Artificial Intelligence in Biomedical, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Artificial Intelligence in Biomedical Market Size by Type (US$ Million), 2021–2026

Table 24. Global Artificial Intelligence in Biomedical Revenue Market Share by Type (2021–2026)

Table 25. Global Artificial Intelligence in Biomedical Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Artificial Intelligence in Biomedical Revenue Market Share by Type (2027–2032)

Table 27. Global Artificial Intelligence in Biomedical Market Size by Application (US$ Million), 2021–2026

Table 28. Global Artificial Intelligence in Biomedical Revenue Market Share by Application (2021–2026)

Table 29. Global Artificial Intelligence in Biomedical Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Artificial Intelligence in Biomedical Revenue Market Share by Application (2027–2032)

Table 31. North America Artificial Intelligence in Biomedical Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Artificial Intelligence in Biomedical Market Size by Country (US$ Million), 2021–2026

Table 33. North America Artificial Intelligence in Biomedical Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Artificial Intelligence in Biomedical Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Artificial Intelligence in Biomedical Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Artificial Intelligence in Biomedical Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Artificial Intelligence in Biomedical Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Artificial Intelligence in Biomedical Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Artificial Intelligence in Biomedical Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Artificial Intelligence in Biomedical Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Artificial Intelligence in Biomedical Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Artificial Intelligence in Biomedical Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Artificial Intelligence in Biomedical Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Artificial Intelligence in Biomedical Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Artificial Intelligence in Biomedical Market Size by Country (US$ Million), 2027–2032

Table 46. AstraZeneca Company Details

Table 47. AstraZeneca Business Overview

Table 48. AstraZeneca Artificial Intelligence in Biomedical Product

Table 49. AstraZeneca Revenue in Artificial Intelligence in Biomedical Business (US$ Million), 2021–2026

Table 50. AstraZeneca Recent Development

Table 51. Thales Group Company Details

Table 52. Thales Group Business Overview

Table 53. Thales Group Artificial Intelligence in Biomedical Product

Table 54. Thales Group Revenue in Artificial Intelligence in Biomedical Business (US$ Million), 2021–2026

Table 55. Thales Group Recent Development

Table 56. IBM Corp. Company Details

Table 57. IBM Corp. Business Overview

Table 58. IBM Corp. Artificial Intelligence in Biomedical Product

Table 59. IBM Corp. Revenue in Artificial Intelligence in Biomedical Business (US$ Million), 2021–2026

Table 60. IBM Corp. Recent Development

Table 61. ForeSee Medical Company Details

Table 62. ForeSee Medical Business Overview

Table 63. ForeSee Medical Artificial Intelligence in Biomedical Product

Table 64. ForeSee Medical Revenue in Artificial Intelligence in Biomedical Business (US$ Million), 2021–2026

Table 65. ForeSee Medical Recent Development

Table 66. Atomwise Company Details

Table 67. Atomwise Business Overview

Table 68. Atomwise Artificial Intelligence in Biomedical Product

Table 69. Atomwise Revenue in Artificial Intelligence in Biomedical Business (US$ Million), 2021–2026

Table 70. Atomwise Recent Development

Table 71. Cloud Pharmaceuticals Company Details

Table 72. Cloud Pharmaceuticals Business Overview

Table 73. Cloud Pharmaceuticals Artificial Intelligence in Biomedical Product

Table 74. Cloud Pharmaceuticals Revenue in Artificial Intelligence in Biomedical Business (US$ Million), 2021–2026

Table 75. Cloud Pharmaceuticals Recent Development

Table 76. GNS Healthcare Company Details

Table 77. GNS Healthcare Business Overview

Table 78. GNS Healthcare Artificial Intelligence in Biomedical Product

Table 79. GNS Healthcare Revenue in Artificial Intelligence in Biomedical Business (US$ Million), 2021–2026

Table 80. GNS Healthcare Recent Development

Table 81. Microsoft Corporation Company Details

Table 82. Microsoft Corporation Business Overview

Table 83. Microsoft Corporation Artificial Intelligence in Biomedical Product

Table 84. Microsoft Corporation Revenue in Artificial Intelligence in Biomedical Business (US$ Million), 2021–2026

Table 85. Microsoft Corporation Recent Development

Table 86. Novartis AG Company Details

Table 87. Novartis AG Business Overview

Table 88. Novartis AG Artificial Intelligence in Biomedical Product

Table 89. Novartis AG Revenue in Artificial Intelligence in Biomedical Business (US$ Million), 2021–2026

Table 90. Novartis AG Recent Development

Table 91. NVIDIA Corporation Company Details

Table 92. NVIDIA Corporation Business Overview

Table 93. NVIDIA Corporation Artificial Intelligence in Biomedical Product

Table 94. NVIDIA Corporation Revenue in Artificial Intelligence in Biomedical Business (US$ Million), 2021–2026

Table 95. NVIDIA Corporation Recent Development

Table 96. Pfizer Company Details

Table 97. Pfizer Business Overview

Table 98. Pfizer Artificial Intelligence in Biomedical Product

Table 99. Pfizer Revenue in Artificial Intelligence in Biomedical Business (US$ Million), 2021–2026

Table 100. Pfizer Recent Development

Table 101. Recursion Pharmaceuticals Company Details

Table 102. Recursion Pharmaceuticals Business Overview

Table 103. Recursion Pharmaceuticals Artificial Intelligence in Biomedical Product

Table 104. Recursion Pharmaceuticals Revenue in Artificial Intelligence in Biomedical Business (US$ Million), 2021–2026

Table 105. Recursion Pharmaceuticals Recent Development

Table 106. XtalPi Inc Company Details

Table 107. XtalPi Inc Business Overview

Table 108. XtalPi Inc Artificial Intelligence in Biomedical Product

Table 109. XtalPi Inc Revenue in Artificial Intelligence in Biomedical Business (US$ Million), 2021–2026

Table 110. XtalPi Inc Recent Development

Table 111. Aidoc Company Details

Table 112. Aidoc Business Overview

Table 113. Aidoc Artificial Intelligence in Biomedical Product

Table 114. Aidoc Revenue in Artificial Intelligence in Biomedical Business (US$ Million), 2021–2026

Table 115. Aidoc Recent Development

Table 116. AliveCor Company Details

Table 117. AliveCor Business Overview

Table 118. AliveCor Artificial Intelligence in Biomedical Product

Table 119. AliveCor Revenue in Artificial Intelligence in Biomedical Business (US$ Million), 2021–2026

Table 120. AliveCor Recent Development

Table 121. GE Healthcare Company Details

Table 122. GE Healthcare Business Overview

Table 123. GE Healthcare Artificial Intelligence in Biomedical Product

Table 124. GE Healthcare Revenue in Artificial Intelligence in Biomedical Business (US$ Million), 2021–2026

Table 125. GE Healthcare Recent Development

Table 126. Imagen Technologies Company Details

Table 127. Imagen Technologies Business Overview

Table 128. Imagen Technologies Artificial Intelligence in Biomedical Product

Table 129. Imagen Technologies Revenue in Artificial Intelligence in Biomedical Business (US$ Million), 2021–2026

Table 130. Imagen Technologies Recent Development

Table 131. Vuno Inc. Company Details

Table 132. Vuno Inc. Business Overview

Table 133. Vuno Inc. Artificial Intelligence in Biomedical Product

Table 134. Vuno Inc. Revenue in Artificial Intelligence in Biomedical Business (US$ Million), 2021–2026

Table 135. Vuno Inc. Recent Development

Table 136. IDx Technologies Inc. Company Details

Table 137. IDx Technologies Inc. Business Overview

Table 138. IDx Technologies Inc. Artificial Intelligence in Biomedical Product

Table 139. IDx Technologies Inc. Revenue in Artificial Intelligence in Biomedical Business (US$ Million), 2021–2026

Table 140. IDx Technologies Inc. Recent Development

Table 141. Siemens Healthcare GmbH Company Details

Table 142. Siemens Healthcare GmbH Business Overview

Table 143. Siemens Healthcare GmbH Artificial Intelligence in Biomedical Product

Table 144. Siemens Healthcare GmbH Revenue in Artificial Intelligence in Biomedical Business (US$ Million), 2021–2026

Table 145. Siemens Healthcare GmbH Recent Development

Table 146. Neural Analytics Company Details

Table 147. Neural Analytics Business Overview

Table 148. Neural Analytics Artificial Intelligence in Biomedical Product

Table 149. Neural Analytics Revenue in Artificial Intelligence in Biomedical Business (US$ Million), 2021–2026

Table 150. Neural Analytics Recent Development

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

Table 154. Authors List of This Report

List of Figures

Figure 1. Artificial Intelligence in Biomedical Picture

Figure 2. Global Artificial Intelligence in Biomedical Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Artificial Intelligence in Biomedical Market Share by Type: 2025 vs 2032

Figure 4. Hardware Features

Figure 5. Software Features

Figure 6. Global Artificial Intelligence in Biomedical Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Artificial Intelligence in Biomedical Market Share by Application: 2025 vs 2032

Figure 8. Diagnosing Diseases Case Studies

Figure 9. Developing Drugs Case Studies

Figure 10. Personalized Treatment Case Studies

Figure 11. Other Case Studies

Figure 12. Artificial Intelligence in Biomedical Report Years Considered

Figure 13. Global Artificial Intelligence in Biomedical Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Artificial Intelligence in Biomedical Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Artificial Intelligence in Biomedical Market Share by Region: 2025 vs 2032

Figure 16. Global Artificial Intelligence in Biomedical Market Share by Players in 2025

Figure 17. Global Artificial Intelligence in Biomedical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Artificial Intelligence in Biomedical Revenue in 2025

Figure 19. North America Artificial Intelligence in Biomedical Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Artificial Intelligence in Biomedical Market Share by Country (2021–2032)

Figure 21. United States Artificial Intelligence in Biomedical Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Artificial Intelligence in Biomedical Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Artificial Intelligence in Biomedical Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Artificial Intelligence in Biomedical Market Share by Country (2021–2032)

Figure 25. Germany Artificial Intelligence in Biomedical Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Artificial Intelligence in Biomedical Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Artificial Intelligence in Biomedical Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Artificial Intelligence in Biomedical Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Artificial Intelligence in Biomedical Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Artificial Intelligence in Biomedical Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Artificial Intelligence in Biomedical Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Artificial Intelligence in Biomedical Market Share by Region (2021–2032)

Figure 33. China Artificial Intelligence in Biomedical Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Artificial Intelligence in Biomedical Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Artificial Intelligence in Biomedical Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Artificial Intelligence in Biomedical Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Artificial Intelligence in Biomedical Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Artificial Intelligence in Biomedical Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Artificial Intelligence in Biomedical Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Artificial Intelligence in Biomedical Market Share by Country (2021–2032)

Figure 41. Mexico Artificial Intelligence in Biomedical Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Artificial Intelligence in Biomedical Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Artificial Intelligence in Biomedical Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Artificial Intelligence in Biomedical Market Share by Country (2021–2032)

Figure 45. Israel Artificial Intelligence in Biomedical Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Artificial Intelligence in Biomedical Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Artificial Intelligence in Biomedical Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. AstraZeneca Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021–2026)

Figure 49. Thales Group Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021–2026)

Figure 50. IBM Corp. Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021–2026)

Figure 51. ForeSee Medical Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021–2026)

Figure 52. Atomwise Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021–2026)

Figure 53. Cloud Pharmaceuticals Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021–2026)

Figure 54. GNS Healthcare Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021–2026)

Figure 55. Microsoft Corporation Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021–2026)

Figure 56. Novartis AG Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021–2026)

Figure 57. NVIDIA Corporation Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021–2026)

Figure 58. Pfizer Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021–2026)

Figure 59. Recursion Pharmaceuticals Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021–2026)

Figure 60. XtalPi Inc Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021–2026)

Figure 61. Aidoc Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021–2026)

Figure 62. AliveCor Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021–2026)

Figure 63. GE Healthcare Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021–2026)

Figure 64. Imagen Technologies Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021–2026)

Figure 65. Vuno Inc. Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021–2026)

Figure 66. IDx Technologies Inc. Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021–2026)

Figure 67. Siemens Healthcare GmbH Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021–2026)

Figure 68. Neural Analytics Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021–2026)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Artificial Intelligence in Biomedical Market Research Report 2026

Published Date: 2026-01-21

Report Code: QYRE-Auto-33S19787

Global Artificial Intelligence in Biomedical Market Research Report 2026

FEATURED COMPANIES

Artificial Intelligence in Biomedical Market Size

Artificial Intelligence in Biomedical Market

Scope of Artificial Intelligence in Biomedical Market Report

Chapter Outline

FAQ for this report

How fast is Artificial Intelligence in Biomedical Market growing?

What is the Artificial Intelligence in Biomedical Market size in 2032?

Who are the main players in the Artificial Intelligence in Biomedical Market report?

What are the Application segmentation covered in the Artificial Intelligence in Biomedical Market report?

What are the Type segmentation covered in the Artificial Intelligence in Biomedical Market report?

FEATURED COMPANIES